Business Description
Pfizer Inc
NAICS : 325412
SIC : 2834
ISIN : BRPFIZBDR006
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.18 | |||||
Equity-to-Asset | 0.39 | |||||
Debt-to-Equity | 0.8 | |||||
Debt-to-EBITDA | 7.41 | |||||
Interest Coverage | 1.52 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.64 | |||||
Beneish M-Score | -2.35 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.9 | |||||
3-Year EBITDA Growth Rate | -10.4 | |||||
3-Year EPS without NRI Growth Rate | -6.1 | |||||
3-Year FCF Growth Rate | -26.8 | |||||
3-Year Book Growth Rate | 11.5 | |||||
Future 3-5Y EPS without NRI Growth Rate | -1.33 | |||||
Future 3-5Y Total Revenue Growth Rate | 2.67 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 24.03 | |||||
9-Day RSI | 31.71 | |||||
14-Day RSI | 36.67 | |||||
6-1 Month Momentum % | -11.13 | |||||
12-1 Month Momentum % | -31.25 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.91 | |||||
Quick Ratio | 0.69 | |||||
Cash Ratio | 0.27 | |||||
Days Inventory | 144 | |||||
Days Sales Outstanding | 69.57 | |||||
Days Payable | 90.86 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 5.31 | |||||
Dividend Payout Ratio | 0.82 | |||||
3-Year Dividend Growth Rate | 2.6 | |||||
Forward Dividend Yield % | 4.46 | |||||
5-Year Yield-on-Cost % | 6.15 | |||||
3-Year Average Share Buyback Ratio | -0.5 | |||||
Shareholder Yield % | -9.24 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 57.34 | |||||
Operating Margin % | 5.74 | |||||
Net Margin % | 3.62 | |||||
FCF Margin % | 8.11 | |||||
ROE % | 2.2 | |||||
ROA % | 1 | |||||
ROIC % | 3.81 | |||||
ROC (Joel Greenblatt) % | 18.64 | |||||
ROCE % | 1.89 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 70.17 | |||||
Forward PE Ratio | 11.43 | |||||
PE Ratio without NRI | 13.8 | |||||
Shiller PE Ratio | 9.3 | |||||
Price-to-Owner-Earnings | 394.69 | |||||
PEG Ratio | 1.7 | |||||
PS Ratio | 2.46 | |||||
PB Ratio | 1.6 | |||||
Price-to-Free-Cash-Flow | 29.58 | |||||
Price-to-Operating-Cash-Flow | 16.39 | |||||
EV-to-EBIT | 61.58 | |||||
EV-to-Forward-EBIT | 12.52 | |||||
EV-to-EBITDA | 21.05 | |||||
EV-to-Forward-EBITDA | 10.5 | |||||
EV-to-Revenue | 3.44 | |||||
EV-to-Forward-Revenue | 3.35 | |||||
EV-to-FCF | 41.98 | |||||
Price-to-Projected-FCF | 0.45 | |||||
Price-to-Median-PS-Value | 0.61 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.64 | |||||
Earnings Yield (Greenblatt) % | 1.62 | |||||
FCF Yield % | 3.35 | |||||
Forward Rate of Return (Yacktman) % | 31.56 |